About Monrol
Monrol is a Healthcare company based in Kuwait City (Kuwait) founded in 1995, and was acquired by Curium in March 2025. Manufacturer of radiopharmaceuticals and related products. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development. Its legal entity is Eczacıbaşı-Monrol.
Company details
Monrol was founded in 1995 in Kuwait City, Kuwait, as a manufacturer in the radiopharmaceutical sector. Operations include production of lutetium-177 and related products, supported by a global logistics network and manufacturing facilities. Tailor-made solutions for drug development are provided, along with supply services through international affiliates, focusing on theranostic applications.
- Headquarters Kuwait City, Kuwait
- Stage Acquired
- SectorsHealthcare
- Website monrol.com
- Social LinkedIn
- Acquired by Curium (Mar 2025)
- Legal Name Eczacıbaşı-Monrol
- Investors
- Acquired byCurium
(Mar 2025)
Investors in Monrol
Monrol has secured backing from 1 investor. Prominent investors backing the company include Curium Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Curium Pharma is recognized as a leader in radiopharmaceuticals. | 2017 | curiumpharma.com | Paris, France |
Investor details for Monrol
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Monrol
2 dated milestones of Monrol across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Monrol is founded.
- Exit Acquired by Curium.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Monrol
Monrol was founded in 1995.
Monrol is headquartered in Kuwait City, Kuwait.
Monrol was founded in 1995 in Kuwait City, Kuwait, as a manufacturer in the radiopharmaceutical sector. Operations include production of lutetium-177 and related products, supported by a global logistics network and manufacturing facilities. Tailor-made solutions for drug development are provided, along with supply services through international affiliates, focusing on theranostic applications.
Monrol has 1 investor. Key investors include Curium Pharma.
Monrol operates through Eczacıbaşı-Monrol.
Yes. Monrol was acquired by Curium in March 2025.